160 related articles for article (PubMed ID: 22592423)
1. Infliximab in the treatment of amyloidosis secondary to Crohn's disease.
Cabezuelo JB; Egea JP; Ramos F; Torrella E; Muray S; Alcázar C
Nefrologia; 2012 May; 32(3):385-8. PubMed ID: 22592423
[TBL] [Abstract][Full Text] [Related]
2. Effect of infliximab induction therapy on secondary systemic amyloidosis associated with Crohn's disease: case report and review of the literature.
Pukitis A; Zake T; Groma V; Ostrovskis E; Skuja S; Pokrotnieks J
J Gastrointestin Liver Dis; 2013 Sep; 22(3):333-6. PubMed ID: 24078992
[TBL] [Abstract][Full Text] [Related]
3. [Secondary (AA) amyloidosis in Crohn's disease].
Bulum T; Prkacin I; Cavrić G; Sobocan N; Skurla B; Duvnjak L; Bulimbasić S
Acta Med Croatica; 2011; 65(3):271-8. PubMed ID: 22359896
[TBL] [Abstract][Full Text] [Related]
4. Crohn's disease and secondary amyloidosis: early complication? A case report and review of the literature.
Basturk T; Ozagari A; Ozturk T; Kusaslan R; Unsal A
J Ren Care; 2009 Sep; 35(3):147-50. PubMed ID: 19689697
[TBL] [Abstract][Full Text] [Related]
5. Anti-tumor necrosis factor alpha therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: a followup report of tolerability and efficacy.
Gottenberg JE; Merle-Vincent F; Bentaberry F; Allanore Y; Berenbaum F; Fautrel B; Combe B; Durbach A; Sibilia J; Dougados M; Mariette X
Arthritis Rheum; 2003 Jul; 48(7):2019-24. PubMed ID: 12847696
[TBL] [Abstract][Full Text] [Related]
6. Complete remission of nephrotic syndrome secondary to amyloid a amyloidosis in patient with inactive Crohn's disease after treatment by infliximab.
Hassani K; Hamzi MA; El Kabbaj D
Saudi J Kidney Dis Transpl; 2018; 29(2):456-461. PubMed ID: 29657220
[TBL] [Abstract][Full Text] [Related]
7. [Renal amyloidosis complicating Crohn's disease: report of two cases and review of literature].
Elloumi H; Ben Slama A; Arfaoui D; Ghouma M; Sfar S; Ajmi S
Tunis Med; 2006 Apr; 84(4):253-5. PubMed ID: 16832997
[TBL] [Abstract][Full Text] [Related]
8. [A case of systemic AA amyloidosis complicating Crohn's disease].
Muro K; Kobayashi M; Shimizu Y; Kikuchi S; Yamaguchi N; Inadome Y; Watanabe T; Koyama A
Nihon Jinzo Gakkai Shi; 1998 May; 40(4):284-9. PubMed ID: 9654912
[TBL] [Abstract][Full Text] [Related]
9. Successful use of maintenance infliximab for nephropathy in a patient with secondary amyloidosis complicating Crohn's disease.
Tada Y; Ishihara S; Ito T; Matsui K; Sonoyama H; Oka A; Kusunoki R; Fukuba N; Mishima Y; Oshima N; Moriyama I; Yuki T; Kawashima K; Sato S; Adachi K; Ikeuchi H; Kinoshita Y
Intern Med; 2013; 52(17):1899-902. PubMed ID: 23994979
[TBL] [Abstract][Full Text] [Related]
10. Secondary amyloidosis in a patient with long duration Crohn's disease treated with infliximab.
Fidalgo C; Calado J; Cravo M
BioDrugs; 2010 Dec; 24 Suppl 1():15-7. PubMed ID: 21175229
[TBL] [Abstract][Full Text] [Related]
11. [Crohn's disease and amyloidosis. An association to be considered].
Sánchez Lombraña JL; Triviño A; Linares A; Navascués CA; Pérez R; Rodríguez M; Rodrigo L
Rev Esp Enferm Dig; 1991 Nov; 80(5):337-41. PubMed ID: 1768475
[TBL] [Abstract][Full Text] [Related]
12. [Reversible nephrotic syndrome in Crohn's disease complicated with renal amyloidosis].
Larvol L; Cervoni JP; Besnier M; Dupouet L; Beaufils H; Clauvel JP; Levecq H
Gastroenterol Clin Biol; 1998; 22(6-7):639-41. PubMed ID: 9762336
[TBL] [Abstract][Full Text] [Related]
13. Rapid and complete resolution of proteinuria due to renal amyloidosis in a patient with rheumatoid arthritis treated with infliximab.
Elkayam O; Hawkins PN; Lachmann H; Yaron M; Caspi D
Arthritis Rheum; 2002 Oct; 46(10):2571-3. PubMed ID: 12384913
[TBL] [Abstract][Full Text] [Related]
14. Renal cancer in a patient with Crohn's disease and secondary amyloidosis.
Efstratiadis G; Tsiaousis G; Leontsini M; Nikolaidis N; Dimitriadis C; Memmos D
J Nephrol; 2006; 19(4):518-20. PubMed ID: 17048211
[TBL] [Abstract][Full Text] [Related]
15. [Amyloidosis in Crohn disease. Case reports and review of the literature].
Gries E; Singer MV; Goebell H
Med Klin (Munich); 1989 Feb; 84(2):65-71. PubMed ID: 2651860
[TBL] [Abstract][Full Text] [Related]
16. [Amyloid goiter secondary to Crohn's disease].
Gallardo GL; Moya MP; Rey MD; Arroyo MJ; Dávila FM; Sánchez-Covisa MA
Endocrinol Nutr; 2009; 56(7):384-6. PubMed ID: 19883900
[TBL] [Abstract][Full Text] [Related]
17. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease.
Borrelli O; Bascietto C; Viola F; Bueno de Mesquita M; Barbato M; Mancini V; Bosco S; Cucchiara S
Dig Liver Dis; 2004 May; 36(5):342-7. PubMed ID: 15191204
[TBL] [Abstract][Full Text] [Related]
18. Combining infliximab with 6-mercaptopurine/azathioprine for fistula therapy in Crohn's disease.
Ochsenkühn T; Göke B; Sackmann M
Am J Gastroenterol; 2002 Aug; 97(8):2022-5. PubMed ID: 12190171
[TBL] [Abstract][Full Text] [Related]
19. [Nephrotic syndrome as the initial symptom of Crohn disease].
Kullmann F; Kullmann M; Leser HG; Krämer BK; Riegger AJ; Schölmerich J
Z Gastroenterol; 1996 Nov; 34(11):757-62. PubMed ID: 9045538
[TBL] [Abstract][Full Text] [Related]
20. Predictors of infliximab failure after azathioprine withdrawal in Crohn's disease treated with combination therapy.
Oussalah A; Chevaux JB; Fay R; Sandborn WJ; Bigard MA; Peyrin-Biroulet L
Am J Gastroenterol; 2010 May; 105(5):1142-9. PubMed ID: 20389296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
